You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Primary Immunodeficiency (PID)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tool for Primary Immunodeficiency Disease (PID) in Pakistan

Not yet recruiting
  • Primary Immunodeficiency Diseases
  • Primary Immunodeficiency (PID) Rapid Diagnostic Test (RDT)
  • Karachi, Pakistan
    Aga Khan University Hospital
Feb 24, 2023

Test: A Performance Study With Primary Immunodeficiency Tunisia

Not yet recruiting
  • Primary Immunodeficiency Diseases
  • IgG deficiency rapid screening test
  • Tunis, Tunisia
    National Bone Marrow Transplant center
Nov 10, 2022

Primary Immunodeficiency Diseases (PID) Trial (TAK-771)

Not yet recruiting
  • Primary Immunodeficiency Diseases (PID)
  • (no location specified)
Aug 22, 2022

At-Home Subcutaneous Immunoglobulin Replacement Therapy Using

Not yet recruiting
  • Primary Immunodeficiency Diseases (PID)
  • No Intervention
  • (no location specified)
Nov 21, 2023

Primary Immunodeficiency Diseases (PID) Trial (TAK-881)

Not yet recruiting
  • Primary Immunodeficiency Diseases (PID)
  • TAK-881
  • (no location specified)
Oct 4, 2023

Subcutaneous Immunoglobulin Product Cutaquig in Terms of Safety

Recruiting
  • Primary Immunodeficiency Diseases (PID)
  • Moscow, Russian Federation
    Dmitry Rogachev National Research Center of Pediatric Hematology
Aug 8, 2023

Primary Immunodeficiency Diseases (PID) Trial (TAK-881, HYQVIA)

Not yet recruiting
  • Primary Immunodeficiency Diseases (PID)
  • TAK-881
  • HYQVIA
  • (no location specified)
Feb 23, 2023

Conducted in Poland to Document Management and Clinical Outcome

Completed
  • Primary Immunodeficiencies (PID)
    • Gdańsk, Poland
    • +4 more
    Nov 15, 2021

    Primary Immunodeficiency Disease Trial in Japan (IGSC 20% infusion)

    Active, not recruiting
    • Primary Immunodeficiency Disease
    • IGSC 20% infusion
    • Nagoya, Aichi, Japan
    • +7 more
    Jan 4, 2023

    Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

    Recruiting
    • Primary Immunodeficiency (PID)
    • +4 more
    • data collection
    • Pittsburgh, Pennsylvania
      UPMC Children's Hospital of Pittsburgh
    Feb 9, 2022

    Primary Immunodeficiency Diseases (PID) Trial in United States (Immune Globulin Intravenous (Human), 10%)

    Completed
    Has Results
    • Primary Immunodeficiency Diseases (PID)
    • Immune Globulin Intravenous (Human), 10%
    • Los Angeles, California
    • +8 more
    Apr 29, 2021

    Subcutaneous Immunoglobulin in Primary and Secondary

    Not yet recruiting
    • Primary Immune Deficiency Disorder
    • Secondary Immune Deficiency
    • Edmonton, Alberta, Canada
      University of Alberta
    Jun 14, 2022

    Primary Immune Deficiency Trial in Suresnes (MRI procedure)

    Recruiting
    • Primary Immune Deficiency
    • MRI procedure
    • Suresnes, France
      Foch hospital
    Jul 25, 2022

    Primary Immunodeficiency Diseases (PID) Trial in Japan (Immune Globulin Intravenous (IGIV), Immune Globulin Subcutaneous, 20%

    Completed
    • Primary Immunodeficiency Diseases (PID)
    • Immune Globulin Intravenous (IGIV)
    • Immune Globulin Subcutaneous, 20% Solution (IGSC, 20%)
    • Nagoya-shi, Aichi, Japan
    • +7 more
    Feb 23, 2022

    Epstein-Barr Virus (EBV) Infections, Lymphoproliferative Disorders, EBV+ Associated Lymphoma Trial (tabelecleucel)

    Available
    • Epstein-Barr Virus (EBV) Infections
    • +11 more
    • tabelecleucel
    • (no location specified)
    Feb 15, 2022

    Primary Immunodeficiency Disease Trial in United States (Kedrion IVIG 10%)

    Completed
    Has Results
    • Primary Immunodeficiency Disease
    • Kedrion IVIG 10%
    • North Palm Beach, Florida
    • +10 more
    Jan 26, 2022

    Primary Immune Deficiency, COVID Trial in Paris

    Recruiting
    • Primary Immune Deficiency
    • COVID
      • Paris, France
        Imagine Institute
      Sep 1, 2021

      Primary Immunodeficiency, PID Trial in Pittsburgh (CD3/CD19 neg allogeneic BMT)

      Active, not recruiting
      • Primary Immunodeficiency
      • PID
      • CD3/CD19 neg allogeneic BMT
      • Pittsburgh, Pennsylvania
        Children's Hospital of Pittsburgh of University of Pittsburgh Me
      Oct 6, 2021

      Primary Immunodeficiency, Agammaglobulinemia, Hypogammaglobulinemia Trial in Canada, United States (Kedrion IVIG 10%)

      Completed
      Has Results
      • Primary Immunodeficiency
      • +3 more
      • Kedrion IVIG 10%
      • Little Rock, Arkansas
      • +14 more
      Jan 29, 2021

      Primary Immunodeficiency Diseases (PID) Trial in Centennial, North Palm Beach, Dallas (Recombinant human hyaluronidase + immune

      Completed
      • Primary Immunodeficiency Diseases (PID)
      • Recombinant human hyaluronidase + immune globulin intravenous
      • Centennial, Colorado
      • +2 more
      Apr 30, 2021

      Primary Immunodeficiency Disease Trial in Hungary, Italy, Slovakia (Kedrion IVIG 10%)

      Recruiting
      • Primary Immunodeficiency Disease
      • Kedrion IVIG 10%
      • Budapest, Hungary
      • +8 more
      Jun 21, 2021

      Primary Immunodeficiency Diseases (PID) Trial in United States (HYQVIA, GAMMAGARD LIQUID)

      Completed
      • Primary Immunodeficiency Diseases (PID)
      • HYQVIA
      • GAMMAGARD LIQUID
      • Birmingham, Alabama
      • +18 more
      Sep 28, 2022

      Suppurative Lung Disease in Children and Adults

      Recruiting
      • Primary Ciliary Dyskinesia
      • +2 more
      • Genetic Testing for PCD or PID
      • Unaffected Family Member Genetic Testing
      • Palo Alto, California
      • +7 more
      Mar 30, 2022

      Primary Immunodeficiency Diseases (PID) Trial in Canada, United States (Recombinant human hyaluronidase (rHuPH20)+ immune

      Completed
      Has Results
      • Primary Immunodeficiency Diseases (PID)
      • Recombinant human hyaluronidase (rHuPH20)+ immune globulin intravenous (IGIV)
      • Cypress, California
      • +13 more
      Apr 30, 2021

      Primary Immunodeficiency Diseases (PID), Agammaglobulinemia, Hypogammaglobulinemia Trial in Finland, Sweden (Immune Globulin

      Completed
      • Primary Immunodeficiency Diseases (PID)
      • +2 more
      • Immune Globulin Intravenous (Human), 10% TVR (Triple Virally Reduced) Solution
      • Gammagard S/D (Solvent/Detergent)
      • Tampere, Finland
      • +5 more
      Aug 22, 2021